Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

October 10, 2006; 67 (7 suppl 2) Articles

New pharmacologic horizons in the treatment of Parkinson disease

Ubaldo Bonuccelli, Paolo Del Dotto
First published October 9, 2006, DOI: https://doi.org/10.1212/WNL.67.7_suppl_2.S30
Ubaldo Bonuccelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Del Dotto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
New pharmacologic horizons in the treatment of Parkinson disease
Ubaldo Bonuccelli, Paolo Del Dotto
Neurology Oct 2006, 67 (7 suppl 2) S30-S38; DOI: 10.1212/WNL.67.7_suppl_2.S30

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 67 no. 7 suppl 2 S30-S38
DOI: 
https://doi.org/10.1212/WNL.67.7_suppl_2.S30
PubMed: 
17030738

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 9, 2006.

Copyright & Usage: 
© 2006

Author Disclosures

    1. Ubaldo Bonuccelli, MD and
    2. Paolo Del Dotto, MD
  1. Ubaldo Bonuccelli, MD and
  2. Paolo Del Dotto, MD
  1. From the Department of Neuroscience, University of Pisa (U.B.) and Neurology Unit, Hospital of Viareggio (P.D.D.), Pisa, Italy.
  1. Address correspondence and reprint requests to Dr. Ubaldo Bonuccelli, Universita’ Di Pisa, Dip. di Neuroscienze, Via Roma 55, Pisa, Italy; e-mail: u.bonuccelli{at}med.unipi.it
View Full Text

Article usage

Article usage: October 2006 to July 2022

AbstractFullPdfSource
Oct 20063203460Highwire
Nov 20061514200Highwire
Dec 2006712190Highwire
Jan 2007882030Highwire
Feb 2007661780Highwire
Mar 2007782000Highwire
Apr 2007751270Highwire
May 2007661240Highwire
Jun 200749860Highwire
Jul 200756840Highwire
Aug 200743710Highwire
Sep 200754820Highwire
Oct 200766680Highwire
Nov 200753760Highwire
Dec 200744670Highwire
Jan 200856410Highwire
Feb 200848470Highwire
Mar 200840600Highwire
Apr 200853590Highwire
May 200855430Highwire
Jun 200830410Highwire
Jul 200844310Highwire
Aug 200829110Highwire
Sep 200833310Highwire
Oct 200845350Highwire
Nov 200841550Highwire
Dec 200830270Highwire
Jan 200926200Highwire
Feb 200946260Highwire
Mar 200950310Highwire
Apr 200956270Highwire
May 200938190Highwire
Jun 200923320Highwire
Jul 200943100Highwire
Aug 200928170Highwire
Sep 200939270Highwire
Oct 200947290Highwire
Nov 200925130Highwire
Dec 200933120Highwire
Jan 201031130Highwire
Feb 201029190Highwire
Mar 201024180Highwire
Apr 201028160Highwire
May 201035130Highwire
Jun 201026140Highwire
Jul 20102170Highwire
Aug 201035150Highwire
Sep 20101670Highwire
Oct 20103090Highwire
Nov 2010910Highwire
Dec 20102170Highwire
Jan 20112130Highwire
Feb 20112790Highwire
Mar 201134210Highwire
Apr 20112370Highwire
May 20111750Highwire
Jun 20112450Highwire
Jul 20112240Highwire
Aug 20111440Highwire
Sep 20112230Highwire
Oct 20112570Highwire
Nov 20112020Highwire
Dec 20112230Highwire
Jan 20122110Highwire
Feb 20123200Highwire
Mar 20123570Highwire
Apr 20123920Highwire
May 20122600Highwire
Jun 20122200Highwire
Jul 20121820Highwire
Aug 20122340Highwire
Sep 20121620Highwire
Oct 20123250Highwire
Nov 20121360Highwire
Dec 20124030Highwire
Jan 20131930Highwire
Feb 20131900Highwire
Mar 20132910Highwire
Apr 20133840Highwire
May 20132610Highwire
Jun 20132200Highwire
Jul 20132200Highwire
Aug 20131920Highwire
Sep 20132510Highwire
Oct 20133620Highwire
Nov 20134140Highwire
Dec 20132220Highwire
Jan 20142210Highwire
Feb 20142040Highwire
Mar 20142600Highwire
Apr 20143800Highwire
May 20142100Highwire
Jun 20141600Highwire
Jul 20143210Highwire
Aug 20142020Highwire
Sep 20141800Highwire
Oct 20144410Highwire
Nov 20142300Highwire
Dec 20141820Highwire
Jan 20153510Highwire
Feb 20151910Highwire
Mar 20153800Highwire
Apr 20152330Highwire
May 20152600Highwire
Jun 20152800Highwire
Jul 20154120Highwire
Aug 20151520Highwire
Sep 20152930Highwire
Oct 20153840Highwire
Nov 20151500Highwire
Dec 20155710Highwire
Jan 20162610Highwire
Feb 20163510Highwire
Mar 20162910Highwire
Apr 20162400Highwire
May 20164230Highwire
Jun 20163100Highwire
Jul 20161400Highwire
Aug 20161370Highwire
Sep 20164130Highwire
Oct 20163320Highwire
Nov 20162220Highwire
Dec 20165100Highwire
Jan 20176540Highwire
Feb 20171200Highwire
Mar 20172210Highwire
Apr 20172600Highwire
May 20171500Highwire
Jun 20172200Highwire
Jul 20174020Highwire
Aug 20171230Highwire
Sep 20172300Highwire
Oct 20171900Highwire
Nov 2017410Highwire
Dec 20171300Highwire
Jan 20181700Highwire
Feb 20181300Highwire
Mar 20181630Highwire
Apr 20182700Highwire
May 20182400Highwire
Jun 20182510Highwire
Jul 20182110Highwire
Aug 20181700Highwire
Sep 20183700Highwire
Oct 20181400Highwire
Nov 20181100Highwire
Dec 20182400Highwire
Jan 20191200Highwire
Feb 20191600Highwire
Mar 20191800Highwire
Apr 20191300Highwire
May 20192310Highwire
Jun 20191000Highwire
Jul 20191250Highwire
Aug 20191400Highwire
Sep 20192610Highwire
Oct 20192740Highwire
Nov 20191630Highwire
Dec 20191100Highwire
Jan 20204110Highwire
Feb 20201020Highwire
Mar 20202000Highwire
Apr 20201900Highwire
May 20203010Highwire
Jun 20203100Highwire
Jul 20201200Highwire
Aug 20203220Highwire
Sep 20203010Highwire
Oct 20204830Highwire
Nov 20205630Highwire
Dec 20203510Highwire
Jan 20212110Highwire
Feb 20211900Highwire
Mar 20212200Highwire
Apr 20212800Highwire
May 20212000Highwire
Jun 20213100Highwire
Jul 20211600Highwire
Aug 20214610Highwire
Sep 20213610Highwire
Oct 20213100Highwire
Nov 20214510Highwire
Dec 20213110Highwire
Jan 20222500Highwire
Feb 20223500Highwire
Mar 20223000Highwire
Apr 20222500Highwire
May 20223810Highwire
Jun 20223120Highwire
Jul 20223000Highwire

Cited By...

  • 76 Citations
  • Google Scholar

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Neuroprotective agents.
    • New symptomatic drugs for early PD.
    • New symptomatic drugs for motor complications in advanced PD.
    • Continuous dopaminergic stimulation strategies.
    • Nondopaminergic strategies.
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Alert Me

  • Alert me when eletters are published
Neurology: 99 (6)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise